Skip to Main Content

Paper Details

Distinct methylation profiles characterize fusion-positive and fusion-negative rhabdomyosarcoma.
Mod Pathol
34
2015
-FOXO1-binding sites, 11-gene DNA methylation signature, 11-gene signature, 5-aza-2'-deoxycytidine, EMILIN1, FOXO1, PAX3, PAX7, Rhabdomyosarcoma, fusion, fusion-negative rhabdomyosarcoma, fusion-negative subsets, fusion-negative tumors, fusion-positive, fusion-positive and, fusion-positive and fusion-negative rhabdomyosarcoma, fusion-positive rhabdomyosarcoma, fusion-positive tumors, mRNA, multiple fusion-positive cell lines, normal, rhabdomyosarcoma, rhabdomyosarcoma cell lines, rhabdomyosarcoma tumors, target gene, tumors
Author NameAffiliation
Yonghong WangClinical Molecular Profiling Core, Center for Cancer Research, National Cancer Institute
Yonghong WangClinical Molecular Profiling Core, Center for Cancer Research, National Cancer Institute
Holly StevensonClinical Molecular Profiling Core, Center for Cancer Research, National Cancer Institute
Holly StevensonClinical Molecular Profiling Core, Center for Cancer Research, National Cancer Institute
Daniel C EdelmanClinical Molecular Profiling Core, Center for Cancer Research, National Cancer Institute
Daniel C EdelmanClinical Molecular Profiling Core, Center for Cancer Research, National Cancer Institute
Paul S MeltzerClinical Molecular Profiling Core, Center for Cancer Research, National Cancer Institute
Paul S MeltzerClinical Molecular Profiling Core, Center for Cancer Research, National Cancer Institute
Frederic G Barr
Frederic G Barr
  • 1 - 10

Datasets

Release 1.2